HB 4293, the "Veterans Mental Health Innovation Act," allows Oklahoma universities and affiliated research facilities to conduct clinical trials using ibogaine - a substance derived from the Tabernanthe iboga plant - to treat specific medical conditions. It authorizes research for conditions like PTSD, treatment-resistant depression, opioid use disorder, and chronic pain, requiring registration with state health and agriculture agencies and annual reporting. Researchers and qualifying patients participating in approved trials receive legal immunity from penalties for ibogaine use, possession, or distribution under strict compliance with the bill’s requirements. The law explicitly states it does not decriminalize ibogaine for general use, focusing solely on regulated research. All activities must follow detailed study protocols and submit final reports to state legislative leaders.
HB 4412 creates a permanent revolving fund in Oklahoma's State Treasury called the "ADvantage Waiver Home and Community-based Services for Seniors Revolving Fund." This fund, managed by the Oklahoma Health Care Authority, will provide home and community-based care services to seniors who would otherwise require nursing facility placement but choose to remain in home or community settings instead. The fund will be financed using state and federal funds, donations, grants, and other designated contributions, with no annual budget restrictions. It becomes effective July 1, 2026, to support seniors seeking alternatives to nursing home care.
SB 1912, the "Wrongful Life Act," prohibits physicians and healthcare professionals from providing gender transition surgery, hormone therapy, or puberty-blocking drugs to minors under 18, except when "medically necessary" (with gender transition explicitly defined as never meeting this standard). It also bans parents or guardians from consenting to these treatments for minors. The bill creates new civil lawsuits allowing individuals who received such care as minors to sue providers or parents if they claim the treatment prevented future reproductive abilities (childbirth, impregnation, or breastfeeding), with a rebuttable presumption that these abilities would have been possible without the care. It allows for compensatory/punitive damages, attorney fees, and in parent cases, potential child abuse charges if long-term harm is proven. The law takes effect November 1, 2026.
HB 3286 requires all health insurance plans in Oklahoma to cover pregnancy, postpartum, and newborn care services - including support from perinatal doulas, nurse-midwives, and lactation consultants - without cost-sharing like deductibles or copays. It mandates coverage for breast pumps, supplies, feeding aids, and home visits for postpartum support for at least one year after birth. The bill also exempts breast pumps, supplies, and feeding aids from state sales and use taxes. These provisions apply to both private insurance and Oklahoma’s Medicaid program (SoonerCare), directly affecting pregnant individuals, new parents, and healthcare providers.
HB 3675 requires health insurance companies to have a qualified human professional review any adverse decision (like denying coverage) made by an algorithm, artificial intelligence system, or automated decision system before it becomes final. The bill mandates that patients receive clear notices explaining the reasons for denied coverage, the clinical basis for the decision, and how to appeal. It allows AI systems to be used for administrative tasks or fraud detection but prohibits their use in final coverage decisions without human oversight. The law takes effect on November 1, 2026, directly affecting patients, insurers, and utilization review agents in Oklahoma.
SB 1836 requires physicians, physician assistants, advanced practice nurses, and osteopathic physicians to conduct annual mental health screenings using a standardized tool during routine primary care visits. The State Board of Medical Licensure will develop the screening method and educational materials, collaborating with other health boards. This applies only to providers who perform direct patient care, excluding those in non-clinical roles. The law becomes effective November 1, 2026.
SB 2101 creates the Oklahoma Medicine Injury Justice Act, making pharmaceutical companies directly liable in Oklahoma state courts for harm caused by their products. It allows affected Oklahomans to seek compensation for medical costs, lost wages, pain and suffering, and punitive damages in cases of gross negligence or fraud. The bill explicitly overrides federal immunities (like the PREP Act and Vaccine Injury Act) that would otherwise shield companies from state lawsuits. It ensures all claims are heard in Oklahoma courts without mandatory arbitration, preserving access to justice under state constitutional rights. The law takes effect July 1, 2026, and declares an emergency due to the urgency of protecting citizens' health and safety.
HB 1658 regulates laser hair removal practitioners in Oklahoma by requiring all providers to use only FDA-approved devices and hold specific licenses or certifications. It mandates a 40-hour training program for practitioners (completed internally or via third parties under physician oversight), requires facilities to be overseen by a physician (with exemptions for Advanced Practice Registered Nurses), and establishes protocols for patient evaluations, informed consent, and complication management. The law also specifies that physicians must be available for real-time communication during procedures but need not be physically present. This bill directly affects laser hair removal practitioners, clinics, and supervising physicians, becoming effective immediately upon passage as an emergency measure.
HB 2148 regulates pain management clinics in Oklahoma that prescribe opioids, benzodiazepines, barbiturates, or carisoprodol for chronic nonmalignant pain (pain lasting over 90 days unrelated to cancer). It requires these clinics to register with the Oklahoma Bureau of Narcotics, meet ownership standards (51% physician-owned or hospital-run), and avoid staff with revoked DEA licenses or drug-related felony convictions. Clinics failing to comply face registration suspension (up to one year) or revocation, with owners barred from operating new clinics for one year after revocation. The bill directly affects clinics meeting its definition - advertising pain services and prescribing controlled substances to over 50% of non-hospice patients for long-term pain.
SB 1040 amends Oklahoma law to update the appointment process for the Oklahoma Board of Licensed Alcohol and Drug Counselors. It removes an outdated requirement that five of six counselor members must have secured licensure by January 1, 2005, and instead mandates that at appointment, five members must be licensed counselors and one must be certified. The bill requires the Governor to appoint four members from a list provided by the Oklahoma Drug and Alcohol Professional Counselors Association, one from the Oklahoma Substance Abuse Services Alliance, and one from the Oklahoma Citizen Advocates for Recovery and Treatment Association. This change takes effect November 1, 2025, and affects how the board is composed, directly impacting the selection process for state-level alcohol and drug counseling oversight.
